Could a Low-Dose drug ease nerve pain after spinal cord injury?
NCT ID NCT06723561
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This small pilot study tests whether a low dose of naltrexone (4.5 mg daily for 12 weeks) can reduce central neuropathic pain and improve quality of life in people with traumatic spinal cord injury. Ten adults with cervical or thoracic injuries and nerve pain will take the drug and report their pain levels. The goal is to gather initial data to plan a larger, more definitive trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.